We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 10,000 results
  1. Chemokine- and chemokine receptor-based signature predicts immunotherapy response in female colorectal adenocarcinoma patients

    The clinical significance and comprehensive characteristics of chemokines and chemokine receptors in female patients with advanced colorectal...

    Wenjie Zhu, Changlei Wu, ... Jun Huang in Scientific Reports
    Article Open access 04 December 2023
  2. A case report of two instances of colorectal hepatoid adenocarcinoma, accompanied by a comprehensive literature review

    Objective

    The study aimed to explore the clinical and pathological characteristics, survival outcomes, and prognostic factors of colorectal hepatoid...

    Ran Zhang, Yi Yu, ... Jun Chen in Journal of Cancer Research and Clinical Oncology
    Article Open access 10 November 2023
  3. LncRNA LINC02535 Induces Colorectal Adenocarcinoma Progression via Modulating miR-30d-5p/CHD1

    Growing evidence has suggested that lncRNAs play a significant role in the development of colorectal adenocarcinoma. LncRNA LINC02535 was a potential...

    Jiguang Li, Jianhua Xu, ... Si Cheng in Molecular Biotechnology
    Article 28 December 2022
  4. Pathological Features of Colorectal Adenocarcinoma Patients Related to MLH1

    Background

    MLH1, one of the MMR proteins, is linked to DNA replication, its role being to repair the incorrect DNA sequences and to replace them with...

    Alexandru Adrian Bratei, Raluca-Ioana Stefan-van Staden in Cellular and Molecular Bioengineering
    Article 20 February 2024
  5. Colorectal Tumors

    Colorectal cancer represents a major global health problem as it is associated with high incidence and mortality rates, being the second cause of...
    Vlad-Florin Iovănescu, Adrian Săftoiu in Pocket Guide to Advanced Endoscopy in Gastroenterology
    Chapter 2023
  6. Incidence and survival of adenocarcinoma with mixed subtypes in patients with colorectal cancer

    Background

    Limited attention was paid to adenocarcinoma with mixed subtypes (AM) of the colon and rectum due to its low incidence. This study aims to...

    Fan Zhang, Boqi Xu, ... Shan Tong in International Journal of Colorectal Disease
    Article Open access 16 August 2023
  7. Lymph node ratio is a more robust predictor of overall survival than N stage in stage III colorectal adenocarcinoma

    Background

    Lymph node ratio (LNR) may offer superior prognostic stratification in colorectal adenocarcinoma compared with N stage. However, candidate...

    Amir F. Beirat, Justin Z. Amarin, ... Maysa Al-Hussaini in Diagnostic Pathology
    Article Open access 28 February 2024
  8. Tumoricidal properties of thymoquinone on human colorectal adenocarcinoma cells via the modulation of autophagy

    Colorectal cancer (CRC) is deadly anaplastic changes in the gastrointestinal tract with high-rate mortality. In recent years, the application of...

    Mohammad Saleh Moulana, Sanya Haiaty, ... Reza Rahbarghazi in BMC Complementary Medicine and Therapies
    Article Open access 26 March 2024
  9. Higher number of microplastics in tumoral colon tissues from patients with colorectal adenocarcinoma

    Microplastics have been detected in marine and terrestrial ecosystems, yet the toxic effects of microplastics on living organisms are poorly known....

    Meltem Cetin, Fatma Demirkaya Miloglu, ... Halise İnci Gul in Environmental Chemistry Letters
    Article 02 February 2023
  10. The potential role of Listeria monocytogenes in promoting colorectal adenocarcinoma tumorigenic process

    Background

    Listeria monocytogenes is a foodborne pathogen, which can cause a severe illness, especially in people with a weakened immune system or...

    Giulia Baldelli, Mauro De Santi, ... Giuditta Fiorella Schiavano in BMC Microbiology
    Article Open access 15 March 2024
  11. Genoprotective potential of Macaranga species phytochemical compounds on HT-29 human colorectal adenocarcinoma cell line

    Background

    The species of genus Macaranga are widely found in Malaysian secondary forests and has been used as an alternative for treating varieties...

    Ee Ling Siew, Lishantini Pearanpan, ... Nor Fadilah Rajab in Genes and Environment
    Article Open access 30 October 2023
  12. Adenocarcinoma

    Lung cancer is the most common cause of incidence and mortality of major cancers worldwide. Lung cancer incidence was estimated at 2,093,876 cases...
    Chapter 2023
  13. Identification and validation of a novel six-gene signature based on mucinous adenocarcinoma-related gene molecular ty** in colorectal cancer

    Background and objectives

    Colorectal mucinous adenocarcinoma (MAC) is a particular pathological type that has yet to be thoroughly studied. This study...

    Yuxin Man, Dao **n, ... Lingxi Jiang in Discover Oncology
    Article Open access 05 March 2024
  14. The potential therapeutic effect of klotho on cell viability in human colorectal adenocarcinoma HT-29 cells

    Klotho is an anti-aging, anti-inflammator, and anti-oxidative protein and has been shown to important role in tumorigenesis, proliferation, survival,...

    Ayla Eker Sariboyaci, Onur Uysal, ... Sibel Gunes in Medical Oncology
    Article 07 September 2022
  15. Colorectal adenocarcinoma in Uganda: are right-sided and left-sided colon cancers two distinct disease entities?

    Introduction

    In Western countries, right-sided colon cancers (RSCC) present at an older age and advanced stage. Researchers believe that there is a...

    Richard Wismayer, Julius Kiwanuka, ... Michael Odida in World Journal of Surgical Oncology
    Article Open access 22 July 2023
  16. Risk of colorectal adenocarcinoma in men receiving androgen deprivation therapy for prostate cancer; a nationwide cohort study

    Purpose

    To assess whether androgens play a role in explaining the sex related differences in the incidence of colorectal cancer (CRC).

    ...
    Richard Shore, Ji Zhang, ... Mats Lindblad in Cancer Causes & Control
    Article Open access 21 June 2023
  17. Prognosis of carcinoembryonic antigen (CEA) in stage I colorectal adenocarcinoma and development of a prediction model: a retrospective study based on the SEER database

    Background

    To investigate the prognostic significance of preoperative carcinoembryonic antigen (CEA) status in stage I colorectal classical...

    Zhongbiao Chen, Zhimin Lin in Journal of Cancer Research and Clinical Oncology
    Article 16 September 2023
  18. Proteomic Profile of Colorectal Cancer Cell Treated with Coffee

    The risk of develo** colorectal cancer is greatly reduced by dietary polyphenols and bioactive compounds. Coffee is an important source of these...
    Conference paper 2024
  19. Immunohistochemical analysis of Tn antigen expression in colorectal adenocarcinoma and precursor lesions

    Background

    The Tn antigen (CD175) is an O-glycan expressed in various types of human adenocarcinomas, including colorectal cancer (CRC), though prior...

    Gabrielle E. Dombek, Ana Sofia Ore, ... Richard D. Cummings in BMC Cancer
    Article Open access 07 December 2022
  20. The impact of SLC10A3 on prognosis and immune microenvironment in colorectal adenocarcinoma

    Background

    SLC10A3, a gene upregulated in pan-cancer, lacks full understanding regarding its prognostic implications and association with immune...

    Bangting Wang, Wentao Fan, ... Yan Wang in European Journal of Medical Research
    Article Open access 04 January 2024
Did you find what you were looking for? Share feedback.